Autres langues Angiolab, Inc.

Actions

Cours en clôture Korea S.E. 23/09/2026			Varia. 5j.	Varia. 1 janv.
2 465,00 ^KRW	-15,00%		-26,20%	+0,20%

30/11/21	Angiolab, Inc. announced that it has received KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.
17/11/21	Angiolab, Inc. announced that it expects to receive KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.
24/09/20	Hanyang Securities Co., Ltd., Investment Arm and Sun-Tae Kim acquired 2.9% stake in Angiolab, Inc. from KB 12-1 Venture Fund of KB Investment Co., Ltd. for KRW 1.2 billion.
18/09/20	Angiolab, Inc. cancelled the acquisition of NH Special Purpose Acquisition 13 Co., Ltd. from BNK Venture Investment and others in a reverse merger transaction.
29/06/20	Angiolab, Inc. signed a contract to acquire NH Special Purpose Acquisition 13 Co., Ltd. from BNK Venture Investment and others in a reverse merger transaction for KRW 66.3 billion.
19/07/19	Angiolab, Inc. announced that it has received KRW 2.999988 billion in funding from Dt& Investment Co.,Ltd.
28/06/19	Angiolab, Inc. announced that it expects to receive KRW 2.999988 billion in funding from Dt& Investment Co.,Ltd. and another investor
16/04/18	Angiolab, Inc. announced that it has received KRW 646.1616 million in funding from Yuanta Venture Capital Corp.
08/10/14	Angiolab, Inc. announced that it has received KRW 1 billion in funding from Yuanta venture capital.